Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

By afschroeder • October 14, 2025

Chan AA, Sankar K, Reckamp KL, Díaz B, Lee DJ. Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer. Sci Rep. 2025 Oct 13;15(1):35597. doi: 10.1038/s41598-025-11897-9. PMID: 41083501.

Tags: Cedars Sinai DoM, Dermatology, Harbor UCLA, Hematology/Oncology, Lung adenocarcinoma, NMT1, Publications, survival, The Cancer Genome Atlas, TIMM17A

Related Posts

A CD57+ CD8 T cell subset links cytotoxic T cell cytotoxicity to fibrotic lung disease in systemic sclerosis

Sasaki T, Cao Y, Sowerby JM, Higashioka K, Marks KE, Elahee M, Kamiya M, Dellaripa PF, Ainsworth RI, Taylor KE, Bottini N, Wolters P, Kim[...]

Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design

Plutzky J, Taub PR, Bhatt DL, Al Dhaybi O, Aroda VR, Basile JN, Bloch MJ, Budoff M, Busch RS, Buse JB, Cheung D, Christofides EA,[...]

Corrigendum to “Deep learning in fetal, infant, and toddler neuroimaging research”[Dev. Cognit. Neurosci. (2026), 101680]

Chin JH, Wyburd MK, Ayzenberg V, Bayet L, Bilgic B, Chen EM, Chen Y, Dineen Á, Fujita S, Liu J, Jun Y, Camacho MC, Zöllei[...]